Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Credit agrmnt [a]
Acq. announced
Quarterly results
Appointed director
CC transcript
CVS HEALTH Corp (CVS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
08/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "CVS Health Launches Cordavis"
08/17/2023 8-K Regulation FD Disclosure  Interactive Data
08/04/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/03/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
07/20/2023 8-K Quarterly results
06/01/2023 424B2 Form 424B2 - Prospectus [Rule 424(b)(2)]:
05/31/2023 8-K Regulation FD Disclosure  Interactive Data
05/30/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
05/25/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
05/24/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/05/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/03/2023 PX14A6G Form PX14A6G - Notice of exempt solicitation submitted by non-management:
05/03/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/03/2023 8-K Quarterly results
05/02/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
04/26/2023 PX14A6G Form PX14A6G - Notice of exempt solicitation submitted by non-management:
03/30/2023 8-K Quarterly results
03/29/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/07/2023 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
02/13/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
02/13/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
02/10/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 8.9% stake in CVS Health Corp.
02/08/2023 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
02/08/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "AGREEMENT AND PLAN OF MERGER",
"Form of Voting Agreement"
02/08/2023 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
02/08/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "CVS HEALTH REPORTS STRONG FOURTH QUARTER AND FULL-YEAR 2022 RESULTS"
02/08/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "CVS Health to Acquire Oak Street Health",
"Presentation materials related to the Merger, February 8, 2023"
02/07/2023 SC 13G/A BlackRock Inc. reports a 7.4% stake in CVS HEALTH CORPORATION
01/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Investor contact"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy